De Matteis, Carlo
Petruzzelli, Stefano
Graziano, Giusi
Novielli, Fabio
Di Buduo, Ersilia
Cantatore, Salvatore
Berardi, Elsa
Antonica, Gianfranco
Arconzo, Maria
Cariello, Marica
Florio, Marilina
Crudele, Lucilla
Moschetta, Antonio
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (PE0000015, Concession Decree No. 1243 of 2 August 2022 adopted by the Italian Ministry of University and Research, CUP H33C22000680006, project title “Ageing well in an ageing society—A novel public-private alliance to generate socioeconomic, biomedical and technological solutions for an inclusive Italian ageing society– AGE-IT”)
Ministero dell'Università e della Ricerca (D93C22000890001, project title “ON Foods—Research and innovation network on food and nutrition Sustainability, Safety and Security—Working ON Foods”)
Fondazione AIRC per la ricerca sul cancro ETS (IG 2019 “Regulation of lipid metabolic pathways in the gut liver axis: relevance in hepatocarcinoma” Id 23239)
Ministero della Salute (PNRR M6C2—Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN”, project code PNRR-MR1-2022-12376395. CUP H93C22000780006, project title: Italian Autoimmune Liver Disease (IT-AILD) Clinical Research Network (CRN))
Article History
Received: 12 June 2025
Accepted: 26 July 2025
First Online: 11 August 2025
Declarations
:
: This study was approved by the Ethics Committee (Interdisciplinary Department of Medicine; n. 311, MSC/PBMC/2015, approved on 12 January 2015) of the Azienda Ospedaliero-Universitaria Policlinico di Bari (Bari, Italy) in accordance with the requirements of the Declaration of Helsinki. In accordance with the approved Ethics Committee, only patients who were already 18 years old or older were included. Informed consent was obtained from all subjects involved in the study.
: Not applicable.
: The authors declare no competing interests.